ArticleOncoTargets and therapy2019
FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC.
Dan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncoTargets and therapy2019
Dan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.